Compare BRT & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRT | FOCL |
|---|---|---|
| Founded | 1972 | 1979 |
| Country | United States | France |
| Employees | 12 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.0M | 222.4M |
| IPO Year | 1994 | 1998 |
| Metric | BRT | FOCL |
|---|---|---|
| Price | $13.47 | $4.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $18.00 | $8.80 |
| AVG Volume (30 Days) | 54.1K | ★ 76.1K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 7.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $97,028,000.00 | $70,527,000.00 |
| Revenue This Year | $1.10 | N/A |
| Revenue Next Year | $7.98 | $34.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.46 | ★ 1.63 |
| 52 Week Low | $13.18 | $4.00 |
| 52 Week High | $15.63 | $6.40 |
| Indicator | BRT | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 39.96 | 42.52 |
| Support Level | $13.18 | $4.01 |
| Resistance Level | $14.87 | $4.63 |
| Average True Range (ATR) | 0.29 | 0.28 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 28.99 | 11.99 |
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.